Clinical trial for personalized kidney cancer vaccine

A research center has enrolled its first patient in a phase 3 clinical trial that uses a person’s own kidney cancer cells to make a vaccine tailored to kill those cells.

from Latest Science News -- ScienceDaily http://ift.tt/1EjNJgG
via